Latest Baxter International Stories
New study “Global Hemophilia Market Report: 2012 Edition” developed by Koncept Analytics has been recently published by Market Publishers Ltd.
On April 27th, 2012, Baxter, the company manufacturing Gammagard, announced positive Phase III clinical data of Gammagard Liquid 10% [Immune Globulin Intravenous (Human)], used for treating multifocal
CHICAGO, June 9, 2011 /PRNewswire/ -- Today a Cook County jury awarded $625,000 to the estate of a 63 year old Chicago area man, Steven Johansen, who was administered Baxter blood thinner that contained a contaminated ingredient Baxter sourced from China.
TAI'AN, China, Dec. 6, 2010 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc.
Company must provide transition guide for facilities using Colleague infusion pumps SILVER SPRING, Md., July 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today required Baxter Healthcare Corp.
SILVER SPRING, Md., May 3 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration sent a letter to Baxter Healthcare Corp. on April 30 ordering the company to recall and destroy all of its Colleague Volumetric Infusion Pumps (Colleague pumps) currently in use in the United States.
Readers are referred to the cautionary notes regarding Forward-looking information at the end of this release Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, April 20 /PRNewswire-FirstCall/ - Cangene Corporation today reports that it has signed a new agreement with Baxter Healthcare Corporation under which Cangene assumes the commercialization rights to WinRho(R) SDF (Rho(D) Immune Globulin Intravenous (Human)) for the U.S.
NEW YORK, Nov.
CLINTON, N.J., Oct. 19 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that Board Chairman David E. Shaw is retiring from the board. Current Ikaria CEO Daniel Tasse has been named Chairman of the Board, succeeding Shaw, who has served as Chairman since 2007.
- Large; stout; burly.